ERBB2 and neoplasm: In evaluating HER2 expression in GC, several guidelines have indicated that a minimum of five biopsy specimens should be obtained to account for intratumoural heterogeneity and to provide sufficient tumour specimens for diagnosis and biomarker testing.9 We also found a higher accordance rate in cases with more than five biopsies (Supplementary Table 2).